The Patent Finder

Novarx Corporation

Also on record
Records under this name other than patents Novarx Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 7 of 7 · Back to Novarx Corporation

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,101,543Genetically modified cells expressing a TGFβ inhibitor, the cells being lung cancer cells
Term ended
Term ended Nov 2, 2022 · USPTO record
Term endedTerm ended Nov 2, 2022USPTO record
US 7,740,837Genetically modified cells expressing a TGF beta inhibitor, the cells being lung cancer cells
Term ended
Term ended Nov 22, 2021 · USPTO record
Term endedTerm ended Nov 22, 2021USPTO record
US 8,293,252Universal tumor cell vaccine for anti cancer therapeutic and prophylactic utilization
Lapsed on the fee record
Ended Oct 23, 2020 · USPTO record
Lapsed on the fee recordEnded Oct 23, 2020USPTO record
US 6,120,763Compositions and methods for enhanced tumor cell immunity in vivo
Term ended
Term ended Nov 12, 2017 · USPTO record
Term endedTerm ended Nov 12, 2017USPTO record
US 6,447,769Compositions and methods for enhanced tumor cell immunity in vivo
Term ended
Ended no later than Jul 18, 2014 · USPTO record
Term endedEnded no later than Jul 18, 2014USPTO record
US 8,444,964Compositions and methods for enhanced tumor cell immunity in vivo
Term ended
Ended no later than Jul 18, 2014 · USPTO record
Term endedEnded no later than Jul 18, 2014USPTO record
US 5,772,995Compositions and methods for enhanced tumor cell immunity in vivo
Term ended
Term ended no later than Jun 30, 2018 · Low confidence
Term endedTerm ended no later than Jun 30, 2018Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited